Biosciences, announced that its collaboration partner, PeriNess has entered into a Clinical Study Agreement to support an ...
OS Therapies (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that OST-HER2 is featured in ...
Biosciences’ collaboration partner, PeriNess has entered into a Clinical Study Agreement to support an exploratory clinical ...
BETTENDORF, Iowa (KWQC) - A Bettendorf teen passed way after a battle with bone cancer on March 20. 15-year-old Zach Maxwell ...
Key data will be presented from the Company’s Phase 2b clinical trial of OST-HER2 in the prevention of recurrent, fully resected, lung metastatic osteosarcoma. This data will be compared with a ...
3don MSN
We recently published a list of 10 Penny Stocks With Huge Upside Potential According To Analysts. In this article, we are ...
Sophie Fulton was diagnosed with a rare bone cancer last year, and after losing part of her leg is now struggling with living ...
is indicated for the treatment of canine osteosarcoma, a deadly form of bone cancer. Large and giant breed dogs, such as Golden Retrievers, Boxers, Greyhounds, Labradors and German Shepherds ...
A devastated family are being forced to leave their home of 12 years after their daughter was diagnosed with rare bone cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback